TUESDAY, SEPTEMBER 19, 2017

GAVI Alliance names new director of U.S. strategy

The GAVI Alliance appointed global health leader Natasha Bilimoria to the position of director of U.S. strategy on Wednesday to lead GAVI's attempt to mobilize U.S. support to fund childhood immunization efforts. Read More »

IDSA issues new vaccine guideline for immunocompromised patients

The Infectious Diseases Society of America issued a new guideline on Thursday to recommend that individuals with compromised immune systems get the flu shot and other vaccinations. Read More »

H7N9 avian flu strain poorly adapted for infecting humans

Researchers at The Scripps Research Institute said on Thursday that avian influenza virus H7N9 does not have the ability to easily infect humans. Read More »

African nations contribute more than $150 million to Global Fund

The Global Fund to fight AIDS, Tuberculosis and Malaria announced on Friday that several African nations pledged more than $150 million to the Global Fund in an international effort to fight AIDS. Read More »

ART could save 15.1 million years of life in South Africa by 2030

HIV Read More »

Scientists determine how mosquitoes are attracted to humans

Mosquito Read More »

Tuberculosis vaccine might help prevent MS

Tuberculosis Read More »

Hong Kong announces second confirmed case of H7N9 avian flu

The Centre for Health Protection of the Department of Health of Hong Kong announced on Friday its second confirmed case of avian influenza A H7N9 and asked the public to take precautions against infection. Read More »

EC approves Fluenz Tetra for flu prevention in children

AstraZeneca, a biopharmaceutical company, announced on Friday that the European Commission granted marketing authorization to Fluenz Tetra for the prevention of seasonal influenza in children. Read More »

Novartis supplies meningitis B vaccine to Princeton to stem outbreak

Novartis, a Basel, Switzerland-based pharmaceutical company, announced on Monday that it is supplying a meningococcal serogroup B vaccine to Princeton University to stem a campus outbreak that affected at least eight students. Read More »

Health Canada approves Bexsero* Meningococcal B vaccine

Novartis said on Monday that Health Canada approved Meningococcal B vaccine Bexsero*, the first broad coverage vaccine for use against MenB in infants, toddlers and adolescents. Read More »

FluNada available in more than 5,000 pharmacies this season

Influenza Read More »

Red Cross appeals for more donations to Haitian cholera epidemic

The International Federation of Red Cross and Red Crescent Societies issued an international appeal on Thursday requesting approximately $12.7 million to battle the cholera epidemic in Haiti and the Dominican Republic. Read More »

GAVI to support new pneumococcal vaccine campaign in Afghanistan

Afghanistan will soon begin vaccinating more than 1.2 million children against pneumococcal disease annually with support of the GAVI Alliance, GAVI announced on Saturday. Read More »

Cases of malaria increase in U.S. due to international travel

  Read More »

Johnson & Johnson launches pediatric HIV treatment program

Janssen, the pharmaceutical companies of Johnson & Johnson, announced on Monday that it launched a program to donate pediatric HIV treatment to children and adolescents in need in sub-Saharan Africa. Read More »

FDA authorizes expansion of clinical trial on flu therapeutic

Hemispherx Biopharma, Inc., a Philadelphia-based specialty pharmaceutical company, announced on Monday that the U.S. Food and Drug Administration expanded a clinical trial for Ampligen, an experimental flu therapeutic. Read More »

Stellar Biotechnologies announces patents for C. diff immunotherapy technology

Stellar Biotechnologies, Inc., a Port Hueneme, California-based immune-stimulating protein development company, announced the issuance on Monday of two additional patents covering its immunotherapy technology for the treatment of Clostridium difficile infection. Read More »

Two chikungunya cases confirmed in St. Martin

Mosquito Read More »

ECDC releases updated risk assessment for poliovirus

The European Centre for Disease Prevention and Control updated its risk assessment of poliovirus on Tuesday with regard to the confirmed presence of wild poliovirus and poliomyelitis strains in the Middle East. Read More »